About the Depo-Provera litigation
Depo-Provera (medroxyprogesterone acetate) is an injectable contraceptive used by millions of women. In 2024, a large study published in a leading medical journal reported that prolonged use of medroxyprogesterone acetate was associated with a significantly increased risk of intracranial meningioma — a tumor that forms in the membranes surrounding the brain.
While meningiomas are often non-cancerous, they can require invasive brain surgery, radiation, and lifelong monitoring, and can cause vision problems, seizures, and neurological damage.
Lawsuits allege that the manufacturer knew or should have known about this risk and failed to warn patients and doctors. If you received Depo-Provera injections and were later diagnosed with a meningioma, you may be entitled to compensation.